Aims

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer. We can either treat the whole prostate or only a specific area of the prostate. The ablation device is inserted in the patient’s urethra. During ablation high-intensity ultrasound waves will destroy the prostate tissue. The ablation process is continuously monitored by real-time MR temperature mapping. A special balloon is inserted in the rectum to cool the rectal wall and to prevent it from heating.
 
go to main content
Research MRI-guided Transurethral UltraSound Ablation

About this research group

This research group performs MRI-guided Transurethral UltraSound Ablation (TULSA) in the prostate.

Research group leader

prof. dr. Jurgen Fütterer

contact form

Aims

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer. read more

Research within MITeC

The TULSA treatment is performed at the MITeC facility, under real-time MRI guidance. So, during the treatment, the patient is in the MR-scanner. MITeC page

Connected to

Collaboration partner(s)